1. 1) Ohtaki K, Umetsu N, Asashita T, et al. Cooperation between community pharmacies and hospitals: contribution to the efficacy and safety of drug therapy through a tracing report system from insurance dispensing pharmacies with the intervention of hospital pharmacists. Medicine and Drug Journal, 44, 954–960 (2008).
2. 2) Voll ML, Yap KD, Terpstra WE, Crul M. Potential drug–drug interactions between anti-cancer agents and community pharmacy dispensed drugs. Pharm. World Sci., 32, 575–580 (2010).
3. 3) Ministry of Health, Labour and Welfare. “Statistics of medical care activities in public health insurance 2020 (updated 30 June, 2021).”: ‹https://www.mhlw.go.jp/toukei/saikin/hw/sinryo/tyosa20/dl/ika.pdf›, accessed 25 November, 2021.
4. 4) Suzuki R, Wakita E, Kakigoshi S, Nakamura A, Hirano A, Nagaoka K, Fukatsu S. The usefulness of information sharing using information liaison forms. Journal of Japanese Society of Hospital Pharmacists, 54, 825–833 (2018).
5. 5) Tasaka Y, Tanaka A, Ido K, Tanaka M, Araki H. Estimation of the economic impact associated with pharmaceutical interventions. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences), 40, 208–214 (2014).